NFL Biosciences SA (ALNFL.PA)
EUR 1.88
(-2.59%)
EUR 1.88
(-2.59%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | -1.1 Million EUR | 0.0% |
| 2022 | - EUR | 0.0% |
| 2021 | - EUR | 0.0% |
| 2020 | - EUR | 0.0% |
| 2019 | - EUR | 0.0% |
| 2018 | - EUR | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | - EUR | 100.0% |
| 2023 Q4 | -1.1 Million EUR | -307.45% |
| 2023 FY | - EUR | 0.0% |
| 2023 Q2 | -272.09 Thousand EUR | 0.0% |
| 2022 FY | - EUR | 0.0% |
| 2022 Q4 | - EUR | -100.0% |
| 2022 Q2 | 120.18 Thousand EUR | 0.0% |
| 2021 FY | - EUR | 0.0% |
| 2021 Q2 | - EUR | 0.0% |
| 2020 FY | - EUR | 0.0% |
| 2019 FY | - EUR | 0.0% |
| 2018 FY | - EUR | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| ABIONYX Pharma SA | 221 Thousand EUR | 601.654% |
| ABIVAX Société Anonyme | 1.00 EUR | 110865700.0% |
| Adocia SA | 272 Thousand EUR | 507.594% |
| Aelis Farma SA | 53 Thousand EUR | 2191.804% |
| Biophytis S.A. | - EUR | Infinity% |
| Advicenne S.A. | 1.74 Million EUR | 163.679% |
| genOway Société anonyme | 982.75 Thousand EUR | 212.811% |
| IntegraGen SA | 311.44 Thousand EUR | 455.967% |
| Medesis Pharma S.A. | 164.62 Thousand EUR | 773.456% |
| Neovacs S.A. | - EUR | Infinity% |
| Plant Advanced Technologies SA | 1.22 Million EUR | 190.535% |
| Quantum Genomics Société Anonyme | -119.17 Thousand EUR | -830.268% |
| Sensorion SA | - EUR | Infinity% |
| Theranexus Société Anonyme | - EUR | Infinity% |
| TME Pharma N.V. | 91 Thousand EUR | 1318.303% |
| Valbiotis SA | 1 Million EUR | 210.314% |
| TheraVet SA | 123.34 Thousand EUR | 998.847% |
| Valerio Therapeutics Société anonyme | 1.00 EUR | 110865700.0% |
| argenx SE | 281.12 Million EUR | 100.394% |
| BioSenic S.A. | - EUR | Infinity% |
| Celyad Oncology SA | 1.26 Million EUR | 187.989% |
| DBV Technologies S.A. | 1.00 USD | 110865700.0% |
| Galapagos NV | 73.97 Million EUR | 101.499% |
| Genfit S.A. | 4000.00 EUR | 27816.4% |
| GeNeuro SA | - EUR | Infinity% |
| Hyloris Pharmaceuticals SA | 1.00 EUR | 110865700.0% |
| Innate Pharma S.A. | 1.00 EUR | 110865700.0% |
| Inventiva S.A. | 417 Thousand EUR | 365.865% |
| MaaT Pharma SA | 190 Thousand EUR | 683.503% |
| MedinCell S.A. | -6.71 Million EUR | 83.487% |
| Nanobiotix S.A. | 200 Thousand EUR | 654.328% |
| Onward Medical N.V. | 936 Thousand EUR | 218.446% |
| Oryzon Genomics S.A. | 6029.00 EUR | 18488.721% |
| OSE Immunotherapeutics SA | - EUR | Infinity% |
| Oxurion NV | 128 Thousand EUR | 966.138% |
| Pharming Group N.V. | 51.38 Million EUR | 102.158% |
| Poxel S.A. | 2.95 Million EUR | 137.505% |
| GenSight Biologics S.A. | 1.00 EUR | 110865700.0% |
| Transgene SA | - EUR | Infinity% |
| Financière de Tubize SA | - EUR | Infinity% |
| UCB SA | 1.03 Billion EUR | 100.108% |
| Valneva SE | 44.46 Million EUR | 102.493% |
| Vivoryon Therapeutics N.V. | 1.00 EUR | 110865700.0% |